The New EU Design Reform: Here Is What You Should Know!

Two recent European court cases—Getty Images vs Stability AI and Gema vs OpenAI—have delivered contrasting rulings on generative AI and copyright infringement, with significant implications for how businesses assess legal risks when using AI models. While one court found no infringement in AI training processes, the other ruled that memorized copyrighted content in model outputs constitutes unlawful reproduction, highlighting the urgent need for Danish companies to clarify their AI roles and imp

To nye europæiske domme om generativ AI og ophavsret viser, at både træningsdata og AI-genereret output kan få afgørende betydning i kommende sager. Getty Images mod Stability AI og Gema mod OpenAI illustrerer, hvordan retsstillingen fortsat er uafklaret på tværs af jurisdiktioner. Hvad betyder disse afgørelser for danske virksomheder, der anvender eller udvikler AI-løsninger?

A Danish court has established new criteria for determining co-inventorship in patent disputes, examining what constitutes an independent intellectual contribution under Danish law.

A Danish court ruling over the word "ostepop" illustrates the delicate balance between trademark protection and common language usage. This case demonstrates how seemingly minor linguistic disputes...

Generative AI is transforming antibody patent prosecution at the European Patent Office, where a single word—'routine'—now determines both enablement and obviousness.

The EU Court of Justice faces a pivotal decision on whether medicines approved as monotherapy but labeled for use in combination with other drugs qualify for Supplementary Protection Certificate (SPC) protection as combinations of active ingredients. This referral, stemming from Genmab's attempts to secure SPC protection for loose combinations including daratumumab, could resolve over a decade of legal uncertainty and fundamentally reshape how pharmaceutical companies approach regulatory strategy for combin

Last year, the EPO’s Enlarged Board reshaped how we think about prior art. In decision G 1/23 (2 July 2025), it clarified that products made publicly available before a patent filing date qualify as prior art — even if they cannot be analysed or reproduced.

How can a patent system designed to promote innovation end up stifling it instead? The CEO of HIMPP reveals how the hearing aid industry is fighting back against patent trolls and overly broad patents that threaten genuine innovation. This conversation explores the complex balance between protecting intellectual property and ensuring that defensive patent strategies don't become barriers to technological progress.

In this episode, Stinus Jeppesen, CEO of the Hearing Instrument Manufacturer Patent Partnership (HIMPP), discusses with our host Hanane Fathi Roswall, Ph. D. how this quite unique, non-profit defensive partnership representing more than 90% of the global hearing aid industry, is fighting for innovation by pruning the IP landscape of the industry through validity challenges and acquisition of patents.

Freedom-to-operate (FTO) used to be the analysis a life-science company commissioned before a product launch or a sale. Public funders have moved it to the top of the list — and where they have led, private capital is following.

A Danish court ruling over the word "ostepop" illustrates the delicate balance between trademark protection and common language usage. This case demonstrates how seemingly minor linguistic disputes...

Generative AI is transforming antibody patent prosecution at the European Patent Office, where a single word—'routine'—now determines both enablement and obviousness.

Last year, the EPO’s Enlarged Board reshaped how we think about prior art. In decision G 1/23 (2 July 2025), it clarified that products made publicly available before a patent filing date qualify as prior art — even if they cannot be analysed or reproduced.

In this episode of OPEN ears, the Danish music artist and entrepreneur, Mattis Jacobsen, explores the intersection of creative expression and technological innovation with our host, Hanane Fathi Roswall.

Leadership advisor Tune Hein shares exclusive insights from his five-year experience as an internal specialist at Novo Nordisk during the launch of Wegovy, one of the pharmaceutical industry's most significant obesity drug introductions. What are the 10 core beliefs that propelled Novo Nordisk to become one of the world's most valuable companies, and how did their unconventional approach to scaling, management, and organizational structure drive their success in the competitive obesity drug market?

How can a patent system designed to promote innovation end up stifling it instead? The CEO of HIMPP reveals how the hearing aid industry is fighting back against patent trolls and overly broad patents that threaten genuine innovation. This conversation explores the complex balance between protecting intellectual property and ensuring that defensive patent strategies don't become barriers to technological progress.

In this episode, Stinus Jeppesen, CEO of the Hearing Instrument Manufacturer Patent Partnership (HIMPP), discusses with our host Hanane Fathi Roswall, Ph. D. how this quite unique, non-profit defensive partnership representing more than 90% of the global hearing aid industry, is fighting for innovation by pruning the IP landscape of the industry through validity challenges and acquisition of patents.

Freedom-to-operate (FTO) used to be the analysis a life-science company commissioned before a product launch or a sale. Public funders have moved it to the top of the list — and where they have led, private capital is following.

In this episode, Lea Carina Uhd Frederiksen, a journalist who founded Fantombryg, discusses her unconventional path into the beverage industry with our host, Hanane Fathi Roswall.

In this episode, Gary Cox, Principal at Wrays | Intellectual Property, a leading Australian IP firm with over 106 years of history, shares the fascinating journey of expanding an established Perth firm across the vast Australian continent and the strategic decision to join the global Rouse Group with our host, Hanane Fathi Roswall.